Posts tagged with ‘pharmaceutical’

  • Algae.Tec Successfully Completes $5m Capital Raising With Patersons Securities

    Algae.Tec Ltd has announced that the AUD$5,000,000 (USD$5,354,086.97) Placement through Patersons Securities Limited has been successfully completed. As previously stated, this capital raising will be utilised to fund the fast-tracking of commercial projects recently announced. Algae.Tec Executive Chairman, Roger Stroud, said the Company was extremely pleased with the capital raising. “This again demonstrates that sophisticated investors are aligned with the […]
    0
  • AURORA ALGAE SET TO RAISE $100M

    The company’s  Western Australia operation in Karratha is planned to be increased from the initial 100 hectares of commercial operation to 400 hectares in the next stage, and then 1000 hectares. Aurora Algae began operations in Karratha mid last year and now has its sights on raising $100 million after hitting the $22 million mark a few months ago. The $22 million […]
    0
  • Mar. Drugs, Volume 9, Issue 11 (November 2011), Pages 2164-2487 released

    MDPI announces the publication of the following issue: Mar. Drugs, Volume 9, Issue 11 (November 2011), Pages 2164-2487 at http://www.mdpi.com/1660-3397/9/11/ Table of Contents: Leda Giannuzzi, Daniela Sedan, Ricardo Echenique and Dario Andrinolo Case Report: An Acute Case of Intoxication with Cyanobacteria and Cyanotoxins in Recreational Water in Salto Grande Dam, Argentina Mar. Drugs 2011, 9(11), 2164-2175; doi:10.3390/md9112164 http://www.mdpi.com/1660-3397/9/11/2164/ Gi-Young Kim, Wun-Jae Kim […]
    0
  • Mar. Drugs, Volume 9, Issue 8 (August 2011), Pages 1307-1439: New Issue

    MDPI AG is pleased to announce the publication of the following issue:Mar. Drugs, Volume 9, Issue 8 (August 2011), Pages 1307-1439 at http://www.mdpi.com/1660-3397/9/8/ Table of Contents: Shi-Yie Cheng, Pei-Wen Chen, Hwa-Pyng Chen, Shang-Kwei Wang and Chang-Yih Duh Article: New Cembranolides from the Dongsha Atoll Soft Coral Lobophytum durum Mar. Drugs 2011, 9(8), 1307-1318; doi:10.3390/md9081307 http://www.mdpi.com/1660-3397/9/81307/ Chia-Ying Kao, Jui-Hsin Su, Mei-Chin […]
    0
  • UK University Research Group seeks SME partners to explore the development of three specific marine bio-resources to produce high value products: anti-cancer drugs, oxygenase biocatalysts, anti-microbials

    The marine environment is a very rich source of bio-molecules with therapeutic applications. Blue biotechnology specifically seeks to harness the biodiversity of the marine environment for access to high-value and relatively low-volume biological products. Recent advances in molecular biology (including metagenomic methods) mean that there is now remarkable potential to harness genetic biodiversity from specific marine environments for bio-product preparation. […]
    0
  • Cancer vaccine firm Immunophotonics hopes for clinical trials involving chitin-derived Protectin drug

    A Missouri biotech company developing a laser-guided cancer vaccine therapy is raising money to get into clinical trials by the end of the year. Immunophotonics has so far focused its laser-assisted immunotherapy, called inCVAX, primarily on breast cancer treatment. The two-step device and drug process attacks late-stage metastatic cancer. It first injects a tumor with laser fibers and heats it […]
    0
  • Algenics and NovImmune announce research collaboration to express human antibodies using microalgae

    Algenics announced a new research collaboration with NovImmune to biomanufacture monoclonal therapeutic antibodies using its proprietary expression platform AlgebiosysTM. Two fully human therapeutic antibodies have been retained from NovImmune’s current pipeline to be produced in the PTA microalgal cell line. There are numerous benefits to using microalgal expression systems over current technologies such as advantageous N-glycosylation profile, natural cell robustness […]
    0
  • 7th European Conference on Marine Natural Products in August ’11

    Time: 14 – 18 August, 2011 Place: Strömstad, Sweden Organizer: The Phytochemical Society of Europe and the Division of Pharmacognosy at Uppsala University http://www.fkog.uu.se/7ECMNP/ This conference is the 7th in a series of meetings in the area of marine natural product research which are organized every second year by European researchers. Professor Lars Bohlin and co-workers have received the honorary […]
    0
  • Bayer Healthcare’s Arctic Wonder market test succeeds with Neptune Krill Oil, leading to launch

    Neptune Technologies & Bioressources Inc.  announced recently that Bayer Healthcare, LLC Consumer Care Division has formally launched its Arctic Wonder proprietary Neptune Krill Oil (“NKO”) in the United States in March 2011 after a succesful market test. Bayer’s market test conducted over the last year with NKO® under its Arctic Wonder brand was performed in the US internet direct response […]
    0
  • New Marine Drugs Issue Available

    New publication from www.mdpi.com. Marine Drugs First Evidence of Palytoxin and 42-Hydroxy-palytoxin in the Marine Cyanobacterium Trichodesmium Mar. Drugs 2011, 9(4), 543-560; doi:10.3390/md9040543 http://www.mdpi.com/1660-3397/9/4/543/ Published online: 31 March 2011 Effects of High Salt Stress on Secondary Metabolite Production in the Marine-Derived Fungus Spicaria elegans Mar. Drugs 2011, 9(4), 535-542; doi:10.3390/md9040535 http://www.mdpi.com/1660-3397/9/4/535/ Published online: 31 March 2011 The Acute Toxicity and […]
    0